251 related articles for article (PubMed ID: 10231079)
21. [Epidemiology of hepatitis C and human immunodeficiency virus infections among injecting drug users in Hungary--what's next?].
Gyarmathy VA; Rácz J
Orv Hetil; 2010 Mar; 151(10):365-71. PubMed ID: 20178967
[TBL] [Abstract][Full Text] [Related]
22. Prevention of HIV infection among injection drug users in resource-limited settings.
Vlahov D; Robertson AM; Strathdee SA
Clin Infect Dis; 2010 May; 50 Suppl 3(Suppl 3):S114-21. PubMed ID: 20397939
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics.
Alistar SS; Owens DK; Brandeau ML
PLoS One; 2014; 9(1):e86584. PubMed ID: 24489747
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
[TBL] [Abstract][Full Text] [Related]
25. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
[TBL] [Abstract][Full Text] [Related]
26. Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.
Amundsen EJ; Eskild A; Stigum H; Smith E; Aalen OO
Eur J Public Health; 2003 Sep; 13(3):252-8. PubMed ID: 14533729
[TBL] [Abstract][Full Text] [Related]
27. Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
Mathers BM; Degenhardt L; Adam P; Toskin I; Nashkhoev M; Lyerla R; Rugg D
J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S132-42. PubMed ID: 19901626
[TBL] [Abstract][Full Text] [Related]
28. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand.
Vanichseni S; Kitayaporn D; Mastro TD; Mock PA; Raktham S; Des Jarlais DC; Sujarita S; Srisuwanvilai LO; Young NL; Wasi C; Subbarao S; Heyward WL; Esparza L; Choopanya K
AIDS; 2001 Feb; 15(3):397-405. PubMed ID: 11273220
[TBL] [Abstract][Full Text] [Related]
29. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
30. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
31. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India.
Hangzo C; Chatterjee A; Sarkar S; Zomi GT; Deb BC; Abdul-Quader AS
Addiction; 1997 Jul; 92(7):813-20. PubMed ID: 9293040
[TBL] [Abstract][Full Text] [Related]
32. Where injecting drug users receive HIV counseling and testing.
Valdiserri RO; Jones TS; West GR; Campbell CH; Thompson PI
Public Health Rep; 1993; 108(3):294-8. PubMed ID: 8497566
[TBL] [Abstract][Full Text] [Related]
33. Providing HIV counseling and testing services in methadone maintenance programs.
Cartter ML; Petersen LR; Savage RB; Donagher J; Hadler JL
AIDS; 1990 May; 4(5):463-5. PubMed ID: 2372380
[TBL] [Abstract][Full Text] [Related]
34. High HIV incidence in a cohort of male injection drug users in Delhi, India.
Sarna A; Saraswati LR; Sebastian M; Sharma V; Madan I; Lewis D; Pulerwitz J; Thior I; Tun W
Drug Alcohol Depend; 2014 Jun; 139():106-14. PubMed ID: 24768060
[TBL] [Abstract][Full Text] [Related]
35. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates.
Stopka TJ; Marshall C; Bluthenthal RN; Webb DS; Truax SR
Public Health Rep; 2007; 122 Suppl 2(Suppl 2):68-73. PubMed ID: 17542457
[TBL] [Abstract][Full Text] [Related]
36. NJ offers everything but needle exchange.
AIDS Alert; 1999 Jun; 14(6):63. PubMed ID: 11366408
[TBL] [Abstract][Full Text] [Related]
37. Efficient allocation of resources to prevent HIV infection among injection drug users: the Prevention Point Philadelphia (PPP) needle exchange program.
Harris ZK
Health Econ; 2006 Feb; 15(2):147-58. PubMed ID: 16145716
[TBL] [Abstract][Full Text] [Related]
38. Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China.
Philbin MM; Zhang F
AIDS Care; 2010 May; 22(5):623-9. PubMed ID: 20229375
[TBL] [Abstract][Full Text] [Related]
39. Willingness to pay for methadone maintenance treatment in Vietnamese epicentres of injection-drug-driven HIV infection.
Tran BX
Bull World Health Organ; 2013 Jul; 91(7):475-82. PubMed ID: 23825874
[TBL] [Abstract][Full Text] [Related]
40. Methadone maintenance and hepatitis C virus infection among injecting drug users.
Crofts N; Nigro L; Oman K; Stevenson E; Sherman J
Addiction; 1997 Aug; 92(8):999-1005. PubMed ID: 9376782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
